Role of curative treatment in patients with intermediate-stage hepatocellular carcinoma

被引：0
|
作者：
Yuichi Sugino
Koichiro Yamakado
Takashi Yamanaka
Masashi Fujimori
Atsuhiro Nakatsuka
Haruyuki Takaki
Yoshiyuki Takei
Hajime Sakuma
Shuji Isaji
机构：
[1] Mie University School of Medicine,Department of Radiology
[2] Hyogo College of Medicine,Department of Radiology
[3] Mie University School of Medicine,Department of Gastroenterology and Hepatology
[4] Mie University School of Medicine,Department of Hepato
来源：
Japanese Journal of Radiology | 2017年 / 35卷
关键词：
Intermediate stage; Curative treatment; Treatment allocation; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：254 / 261
页数：7
相关论文
共 50 条
  • [31] Prognostic significance of nodular number in patients undergoing hepatectomy of intermediate-stage hepatocellular carcinoma
    Fan, Zhong-Qi
    Serenari, Matteo
    Lv, Xing
    Schwartz, Myron
    Qiu, Wei
    Pawlik, Timothy M.
    Chen, Zhong
    Zhou, Ya-Hao
    Wang, Xian-Ming
    Chen, Ting-Hao
    Li, Jie
    Zhang, Cheng-Wu
    Wang, Hong
    Zhang, Yao-Ming
    Gu, Wei-Min
    Liang, Ying-Jian
    Diao, Yong-Kang
    Yao, Lan-Qing
    Li, Chao
    Cescon, Matteo
    Wang, Ming-Da
    Sun, Xiao-Dong
    Lau, Wan Yee
    Shen, Feng
    Yang, Tian
    Lv, Guoyue
    BRITISH JOURNAL OF SURGERY, 2024, 111 (03)
  • [32] Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular Carcinoma
    Kudo, Masatoshi
    LIVER CANCER, 2022, 11 (05) : 399 - 406
  • [33] Validation of a Modified Substaging System (Kinki Criteria) for Patients with Intermediate-Stage Hepatocellular Carcinoma
    Arizumi, Tadaaki
    Ueshima, Kazuomi
    Iwanishi, Mina
    Minami, Tomohiro
    Chishina, Hirokazu
    Kono, Masashi
    Takita, Masahiro
    Kitai, Satoshi
    Inoue, Tatsuo
    Yada, Norihisa
    Hagiwara, Satoru
    Ida, Hiroshi
    Minami, Yasunori
    Sakurai, Toshiharu
    Kitano, Masayuki
    Nishida, Naoshi
    Kudo, Masatoshi
    ONCOLOGY, 2015, 89 : 47 - 52
  • [34] Efficacy and safety of hepatic arterial infusion chemotherapy in patients with intermediate-stage hepatocellular carcinoma
    Yamashita, Tatsuya
    Terashima, Takeshi
    Takata, Noboru
    Horii, Rika
    Sunagozaka, Hajime
    Arai, Kuniaki
    Kaneko, Shuichi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 411 - 411
  • [35] May we actually help clinicians select the best systemic treatment for patients with intermediate-stage hepatocellular carcinoma?
    Giannini, Edoardo G.
    Strazzabosco, Mario
    LIVER INTERNATIONAL, 2024, 44 (02) : 272 - 274
  • [36] LEAP-012 trial in progress: Pembrolizumab plus lenvatinib and transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma (HCC) not amenable to curative treatment
    Llovet, J. M.
    El-Khoueiry, A. B.
    Vogel, A.
    Madoff, D. C.
    Finn, R. S.
    Ogasawara, S.
    Ren, Z.
    Mody, K.
    Li, J. Jing
    Siegel, A. B.
    Dubrovsky, L.
    Kudo, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S702 - S703
  • [37] Management of Intermediate-Stage Hepatocellular Carcinoma: Systemic Versus Locoregional Therapy
    Patel, Mikin
    Pillai, Anjana
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 33 (01) : 159 - 172
  • [38] Adjuvant transarterial chemoembolization for intermediate-stage hepatocellular carcinoma with microvascular invasion
    Wang, Xiao-Hui
    Zhou, Qun-Fang
    Wang, Chen-Meng
    Xiang, Cai-Ling
    Song, Ying-Hui
    Li, Shao-Qiang
    Chen, Min-Shan
    Xiang, Shuang-Lin
    Liu, Chang-Jun
    Mao, Xian-Hai
    BRITISH JOURNAL OF SURGERY, 2023, 110 (08) : 913 - 916
  • [39] Comment on "When to Perform Hepatic Resection for Intermediate-Stage Hepatocellular Carcinoma"
    Spacek, Lisa A.
    Solga, Steven F.
    HEPATOLOGY, 2016, 63 (03) : 1050 - 1050
  • [40] LEAP-012 TRIAL IN PROGRESS: PEMBROLIZUMAB, LENVATINIB, AND TRANSARTERIAL CHEMOEMBOLIZATION COMBINATION THERAPY FOR INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA NOT AMENABLE TO CURATIVE TREATMENT
    Vogel, Arndt
    Llovet, Josep M.
    El-Khoueiry, Anthony B.
    Madoff, David C.
    Finn, Richard
    Ogasawara, Sadahisa
    Ren, Zhenggang
    Mody, Kalgi
    Li, Jerry J.
    Siegel, Abby B.
    Dubrovsky, Leonid
    Kudo, Masatoshi
    HEPATOLOGY, 2020, 72 : 697A - 698A
12345